EE20/DRSP (BAY86-5300)

DRUG2 trials

Sponsors

Bayer

Conditions

ContraceptionContraceptives, OralOvulation Inhibition

Phase 3

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

CompletedNCT00567164

BayerContraception, Contraceptives, Oral, Ovulation Inhibition

Start: 2007-10-31End: 2009-11-30Updated: 2014-03-12

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

WithdrawnNCT01331655

BayerContraception

Start: 2013-04-30End: 2014-11-30Updated: 2014-07-15